» Articles » PMID: 371937

Antimitochondrial Antibodies: Reagent Variables May Lead to Diagnostic Error

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1979 Jan 1
PMID 371937
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Laboratory-prepared and commercially obtained fluorescein-labeled rabbit antihuman IgG were compared in performing the antimitochondria antibody (AMA) assay. Identical results were obtained using either of the fluorescent antisera at protein concentrations of 1.5 mg/ml and 1:10 dilutions of patients' sera. Positive AMA tests with either antisera were observed in each of 7 patients with primary biliary cirrhosis (PBC), 2 of 83 patients with miscellaneous hepatic diseases, and in 1 of 24 patients with extrahepatic biliary obstruction (EBO) of 2-24 weeks duration. However, when undiluted commercial fluorescent antiserum (15.8 mg protein/ml) was substituted in the assay, sera from 11 of 23 AMA-negative patients with EBO and 12 of 15 with miscellaneous liver diseases demonstrated an atypical fluorescence located primarily along the periphery of the rat renal tubules. Thus, if the conjugated antibody is not adjusted to an optimal protein concentration, this atypical fluorescence could be interpreted as a positive AMA test and lead to diagnostic error.

Citing Articles

A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.

Leung P, Choi J, Yang G, Woo E, Kenny T, Gershwin M Expert Rev Mol Diagn. 2016; 16(6):697-705.

PMID: 26953925 PMC: 4964877. DOI: 10.1586/14737159.2016.1164038.


A comparative study of passive hemagglutination and immunofluorescence methods for the detection of mitochondrial antibodies in sera from patients with liver diseases.

Katono S Gastroenterol Jpn. 1980; 15(3):233-40.

PMID: 6995220 DOI: 10.1007/BF02774273.

References
1.
Kaplowitz N, Finlayson N, Walmsley P, Thurnherr N, JAVITT N . Hepatobiliary diseases associated with serum antimitochondrial antibody (AMA). Am J Med. 1973; 54(6):725-30. DOI: 10.1016/0002-9343(73)90058-2. View

2.
Richer G, VIALLET A . Mitochondrial antibodies in extrahepatic biliary obstruction. Am J Dig Dis. 1974; 19(8):740-4. DOI: 10.1007/BF01844944. View

3.
Andersen P, BEUTNER E . Defined immunofluorescence studies of cytoplasmic antibodies. Int Arch Allergy Appl Immunol. 1972; 43(5):780-90. DOI: 10.1159/000230894. View

4.
Kantor F, KLATSKIN G . Serological diagnosis of primary biliary cirrhosis: a potential clue to pathogenesis. Trans Assoc Am Physicians. 1967; 80:267-74. View

5.
Doniach D, Roitt I, Walker J, Sherlock S . Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966; 1(3):237-62. PMC: 1579190. View